{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:35:27Z","timestamp":1787596527047,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004481","name":"University of Tehran","doi-asserted-by":"publisher","award":["28669\/06\/25"],"award-info":[{"award-number":["28669\/06\/25"]}],"id":[{"id":"10.13039\/501100004481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jbiotec.2025.10.012","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:44:54Z","timestamp":1761810294000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Synergistic antitumor effects of recombinant Interleukin-21 and 5-fluorouracil: A novel therapeutic approach against hepatocellular carcinoma"],"prefix":"10.1016","volume":"409","author":[{"given":"Mina","family":"Yazdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hajihassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2025.10.012_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10529-024-03544-6","article-title":"Synergistic anticancer effects of interleukin-21 combined with therapeutic peptides in multiple cancer cells","volume":"47","author":"Akram","year":"2024","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/nbt1029","article-title":"Recombinant protein folding and misfolding in Escherichia coli","volume":"22","author":"Baneyx","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2051-1426-2-2","article-title":"Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1\/2 study","volume":"2","author":"Bhatia","year":"2014","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib5","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood-2016-09-738211","article-title":"Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicity","volume":"129","author":"Bhatt","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib6","doi-asserted-by":"crossref","first-page":"23326","DOI":"10.1074\/jbc.M701313200","article-title":"The existence of multiple conformers of interleukin-21 directs engineering of a superpotent analogue","volume":"282","author":"Bondensgaard","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib7","series-title":"Gene Cloning and DNA Analysis: An Introduction","author":"Brown","year":"2016"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.17219\/acem\/68703","article-title":"Interleukin 21 treatment in a murine model as a novel potential cytokine immunotherapy for colon cancer","volume":"27","author":"Chen","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00253-004-1559-9","article-title":"Secretory and extracellular production of recombinant proteins using Escherichia coli","volume":"64","author":"Choi","year":"2004","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2013.7","article-title":"IL-21 modulates activation of NKT cells in patients with stage IV Malignant Melanoma","volume":"2","author":"Coquet","year":"2013","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/696578","article-title":"IL-21: a pleiotropic cytokine with potential applications in oncology","volume":"2015","author":"Croce","year":"2015","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.mpaic.2024.04.003","article-title":"Immune response to infection","volume":"25","author":"Cumming","year":"2024","journal-title":"Anaesth. Intensive Care Med."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib13","series-title":"The MTT Assay: A Method for Error Minimization and Interpretation in Measuring Cytotoxicity and Estimating Cell Viability","author":"Ghasemi","year":"2023"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib14","series-title":"Molecular cloning: a laboratory manual","author":"Green","year":"2012"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/0284186X.2010.509104","article-title":"A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)","volume":"50","author":"Gr\u00fcnwald","year":"2011","journal-title":"Acta Oncol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib16","first-page":"126","article-title":"Optimization of recombinant \u00df-NGF purification using immobilized metal affinity chromatography","volume":"29","author":"Hajihasan","year":"2017","journal-title":"Minerva Biotecnol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib17","first-page":"11850","article-title":"Expression of human nerve growth factor \u03b2 and bacterial protein disulfide isomerase (DsbA) as a fusion protein (DsbA::hNGF) significantly enhances periplasmic production of hNGF \u03b2 in Escherichia coli","volume":"21","author":"Hajihasan","year":"2016","journal-title":"Rom. Biotechnol. Lett."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10529-025-03575-7","article-title":"Optimization of recombinant neurturin expression in Escherichia coli using response surface methodology","volume":"47","author":"Hajihassan","year":"2025","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/10826068.2024.2331203","article-title":"Comparison of the efficiency of the Sec and Tat secretory pathways in the secretion of recombinant neurturin protein using de novo designed signal peptides","volume":"54","author":"Hajihassan","year":"2024","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1369743","article-title":"Therapeutic potential of interleukin-21 in cancer","volume":"15","author":"Isvoranu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01511","article-title":"Enhancing recombinant protein yields in the E. coli PEriplasm by Combining Signal Peptide and Production Rate Screening","volume":"10","author":"Karyolaimos","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/elps.202300286","article-title":"Residual protein analysis by SDS\u2013PAGE in clinically manufactured BM-MSC products","volume":"45","author":"Kilic","year":"2024","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib24","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s11033-018-4427-x","article-title":"Monoclonal antibodies in cancer immunotherapy","volume":"45","author":"Kimiz-Gebologlu","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib25","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e2","article-title":"IL-17 and IL-21: their immunobiology and therapeutic potentials","volume":"24","author":"Koh","year":"2024","journal-title":"Immune Netw."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2004.11.003","article-title":"Recombinant protein secretion in Escherichia coli","volume":"23","author":"Mergulh\u00e3o","year":"2005","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/ol.2012.966","article-title":"Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma","volume":"5","author":"Pan","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib29","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.2011.40.0655","article-title":"Interleukin-21 has activity in patients with metastatic melanoma: a phase II study","volume":"30","author":"Petrella","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/0115701646305738240730113619","article-title":"The study of different signal peptides in improvement of recombinant proteins solubility in E. coli: a review article","volume":"21","author":"Rahmatabadi","year":"2024","journal-title":"Curr. Proteom."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/cche.10447","article-title":"Determination of soluble wheat protein fractions using the Bradford assay","volume":"98","author":"Rekowski","year":"2021","journal-title":"Cereal Chem."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood-2009-08-239996","article-title":"Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas","volume":"115","author":"Sarosiek","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib34","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1158\/1078-0432.CCR-10-1809","article-title":"Safety and clinical effect of subcutaneous human interleukin-21 in patients with metastatic melanoma or renal cell carcinoma: a phase I trial","volume":"16","author":"Schmidt","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4062\/biomolther.2023.196","article-title":"Current development status of cytokines for cancer immunotherapy","volume":"32","author":"Song","year":"2024","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","article-title":"Interleukin-21: basic biology and implications for cancer and autoimmunity","volume":"26","author":"Spolski","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2011.599","article-title":"A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer","volume":"106","author":"Steele","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib38","article-title":"Periplasmic chaperones and prolyl isomerases","volume":"8","author":"Stull","year":"2018","journal-title":"EcoSal"},{"key":"10.1016\/j.jbiotec.2025.10.012_bib39","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib40","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1200\/JCO.2007.14.5193","article-title":"Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma","volume":"26","author":"Thompson","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbiotec.2025.10.012_bib41","first-page":"1697","article-title":"IL\u201121\/IL\u201121R inhibit tumor growth and invasion in non\u2011small cell lung cancer cells via suppressing Wnt\/\u03b2\u2011catenin signaling and PD\u2011L1 expression","volume":"44","author":"Xue","year":"2019","journal-title":"Int. J. Mol. Med."}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165625002676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165625002676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:47:15Z","timestamp":1773301635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165625002676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0168165625002676"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2025.10.012","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic antitumor effects of recombinant Interleukin-21 and 5-fluorouracil: A novel therapeutic approach against hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2025.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}